$7.10
-0.12-1.66%
Pre-Market: Apr 4, 8:51 AM EDT
Comments
Loading...
Anbio Biotechnology Analyst Ratings and Price Targets | NASDAQ:NNNN | Benzinga
Anbio Biotechnology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Anbio Biotechnology Corp from these most-recent analyst ratings.
Analyst Ratings for Anbio Biotechnology
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Anbio Biotechnology (NNNN) stock?
There is no price target for Anbio Biotechnology
What is the most recent analyst rating for Anbio Biotechnology (NNNN)?
There is no analyst for Anbio Biotechnology
When was the last upgrade for Anbio Biotechnology (NNNN)?
There is no last upgrade for Anbio Biotechnology
When was the last downgrade for Anbio Biotechnology (NNNN)?
There is no last downgrade for Anbio Biotechnology.
When is the next analyst rating going to be posted or updated for Anbio Biotechnology (NNNN)?
There is no next analyst rating for Anbio Biotechnology.
Is the Analyst Rating Anbio Biotechnology (NNNN) correct?
There is no next analyst rating for Anbio Biotechnology.
Browse analyst ratings and price targets on all stocks.